Aptevo Therapeutics

APVO • NASDAQ •
Overview Stats Financials News

Quarterly Financials

Values in thousands 2024-03-31 2023-12-31 2023-09-30 2023-06-30
Revenue $0 $902 $0 $0
Gross Profit -106 786 -123 -150
EBITDA -6,877 -6,268 -6,438 -8,028
EBIT -6,983 -6,384 -6,561 -8,178
Net Income -6,834 -5,903 -6,334 -7,948
Net Change In Cash 0 902 0 0
Free Cash Flow -6,651 -5,253 -6,240 -4,803
Cash 10,250 16,904 19,110 21,006
Basic Shares 686 498 285 147

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue $0 $3,114 $12,292 $4,309
Gross Profit -567 2,213 12,292 -13,543
EBITDA -28,311 -64,922 -20,256 -25,390
EBIT -28,878 -28,641 -21,400 -27,494
Net Income -17,411 42,669 -27,313 -18,448
Net Change In Cash 0 3,114 12,292 4,309
Free Cash Flow -11,730 -21,051 -22,392 -29,406
Cash 16,904 22,635 45,044 39,979
Basic Shares 278 115 106 77

Earnings Calls

Quarter EPS
2024-03-31 -$9.95
2023-12-31 -$6.16
2023-09-30 -$0.50
2023-06-30 -$1.23